Direct Effects of Exendin-(9,39) and GLP-1-(9,36)amide on Insulin Action, β-Cell Function, and Glucose Metabolism in Nondiabetic Subjects

Exendin-(9,39) is a competitive antagonist of glucagon-like peptide-1 (GLP-1) at its receptor. However, it is unclear if it has direct and unique effects of its own. We tested the hypothesis that exendin-(9,39) and GLP-1-(9,36)amide have direct effects on hormone secretion and β-cell function as wel...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Sathananthan, Matheni, Farrugia, Luca P., Miles, John M., Piccinini, Francesca, Dalla Man, Chiara, Zinsmeister, Alan R., Cobelli, Claudio, Rizza, Robert A., Vella, Adrian
Formato: Artigo
Idioma:Inglês
Publicado em: American Diabetes Association 2013
Assuntos:
Original Research
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC3717878/
https://ncbi.nlm.nih.gov/pubmed/23545708
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2337/db13-0140
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados